🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 7 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/05/2000 | 32,81 | 33,88 | 32,38 | 33,22 | +1,14% | 4,57% | 614.400 |
| 09/05/2000 | 34,81 | 35,00 | 32,72 | 32,84 | -4,97% | 6,55% | 375.200 |
| 08/05/2000 | 32,75 | 35,00 | 32,63 | 34,56 | -0,90% | 7,25% | 285.000 |
| 05/05/2000 | 34,25 | 35,31 | 32,50 | 34,88 | +9,30% | 8,21% | 290.600 |
| 04/05/2000 | 32,25 | 33,50 | 31,81 | 31,91 | -0,87% | 5,23% | 397.800 |
| 03/05/2000 | 33,50 | 33,75 | 32,00 | 32,19 | -5,33% | 5,22% | 298.200 |
| 02/05/2000 | 33,50 | 36,25 | 32,00 | 34,00 | +4,51% | 12,69% | 742.800 |
| 01/05/2000 | 28,28 | 33,94 | 27,75 | 32,53 | +15,16% | 21,88% | 419.800 |
| 28/04/2000 | 26,00 | 30,25 | 26,00 | 28,25 | +6,60% | 16,35% | 369.400 |
| 27/04/2000 | 24,50 | 26,50 | 23,63 | 26,50 | +6,00% | 11,73% | 135.000 |
| 26/04/2000 | 22,94 | 25,25 | 22,00 | 25,00 | +11,11% | 14,17% | 166.000 |
| 25/04/2000 | 22,06 | 22,75 | 21,50 | 22,50 | +4,65% | 5,67% | 393.000 |
| 24/04/2000 | 23,50 | 23,50 | 21,03 | 21,50 | -6,01% | 10,51% | 327.000 |
| 20/04/2000 | 24,31 | 24,50 | 20,63 | 22,88 | -0,54% | 15,94% | 136.200 |
| 19/04/2000 | 23,19 | 25,25 | 20,00 | 23,00 | +3,37% | 22,64% | 564.200 |
| 18/04/2000 | 20,56 | 23,00 | 20,47 | 22,25 | +10,56% | 12,31% | 454.800 |
| 17/04/2000 | 20,50 | 24,00 | 20,00 | 20,13 | -3,16% | 19,51% | 420.200 |
| 14/04/2000 | 25,00 | 26,38 | 20,50 | 20,78 | -18,50% | 23,50% | 551.600 |
| 13/04/2000 | 27,00 | 27,00 | 25,50 | 25,50 | -5,77% | 5,56% | 1.422.200 |
| 12/04/2000 | 29,75 | 29,94 | 26,78 | 27,06 | -9,79% | 10,61% | 174.800 |
| 11/04/2000 | 30,50 | 31,06 | 28,50 | 30,00 | -2,74% | 8,40% | 547.800 |
| 10/04/2000 | 34,75 | 34,75 | 30,50 | 30,84 | -10,68% | 12,23% | 315.600 |
| 07/04/2000 | 34,75 | 35,00 | 34,25 | 34,53 | -0,45% | 2,16% | 1.275.000 |
| 06/04/2000 | 35,50 | 35,53 | 33,75 | 34,69 | -2,46% | 5,02% | 1.010.000 |
| 05/04/2000 | 34,50 | 37,31 | 32,50 | 35,56 | +1,25% | 13,95% | 697.000 |
| 04/04/2000 | 38,25 | 38,31 | 29,51 | 35,13 | -8,17% | 23,02% | 652.000 |
| 03/04/2000 | 38,39 | 38,91 | 37,88 | 38,25 | -1,61% | 2,69% | 203.800 |
| 31/03/2000 | 36,88 | 39,50 | 36,88 | 38,88 | +5,96% | 7,12% | 594.000 |
| 30/03/2000 | 40,75 | 40,75 | 36,63 | 36,69 | -8,28% | 10,12% | 490.800 |
| 29/03/2000 | 41,50 | 42,50 | 39,88 | 40,00 | -3,69% | 6,33% | 460.200 |